Document is current
Any future updates will be listed below
-
Authors
Ding, Bo https://orcid.org/0000-0002-9585-3377
Ji, Yuan https://orcid.org/0000-0001-9709-7512
Xu, Xiaojie
Cui, Xiaokang
Meng, Xiaoli
Shen, Zhen
Ren, Lihong
Guo, Yinghui
Xing, Sheng
Liu, Shili https://orcid.org/0000-0003-3314-7749
Liu, Min
-
Funding
Funding for this research was provided by:
Formulation and Revision of Standards Programme by Chinese Pharmacopoeia Committee (2020S10)
Shandong Province Key Research and Development Plan (2021CXGC010511)
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 13 August 2025
First Online: 19 August 2025
Declarations
:
: Ms Min Liu is employed by China National Tobacco Corporation Shandong Branch, Jinan, China. Dr Bo Ding, Dr Yuan Ji, Ms Xiaojie Xu, Ms Xiaokang Cui, Ms Xiaoli Meng, Mr Zhen Shen, Ms Lihong Ren, Ms Yinghui Guo, Dr Sheng Xing, and Dr Shili Liu declare no potential conflict of interest.
